NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 23 12:18PM ET
29.53
Dollar change
-0.46
Percentage change
-1.52
%
IndexS&P 500 P/E- EPS (ttm)-1.10 Insider Own0.87% Shs Outstand513.08M Perf Week-3.55%
Market Cap15.16B Forward P/E10.85 EPS next Y2.72 Insider Trans0.00% Shs Float508.69M Perf Month-2.95%
Enterprise Value23.14B PEG- EPS next Q0.61 Inst Own96.75% Short Float3.08% Perf Quarter-11.02%
Income-560.00M P/S1.27 EPS this Y33.04% Inst Trans2.01% Short Ratio3.72 Perf Half Y-0.36%
Sales11.89B P/B2.14 EPS next Y8.30% ROA-2.78% Short Interest15.69M Perf YTD1.28%
Book/sh13.80 P/C6.61 EPS next 5Y16.31% ROE-8.96% 52W High40.49 -27.06% Perf Year-12.44%
Cash/sh4.47 P/FCF55.92 EPS past 3/5Y- - ROIC-3.35% 52W Low26.25 12.51% Perf 3Y-56.46%
Dividend Est.0.90 (3.05%) EV/EBITDA12.99 Sales past 3/5Y-5.95% -1.31% Gross Margin36.01% Volatility1.70% 1.62% Perf 5Y-65.25%
Dividend TTM0.80 (2.71%) EV/Sales1.95 EPS Y/Y TTM-138.32% Oper. Margin7.33% ATR (14)0.79 Perf 10Y-19.98%
Dividend Ex-DateMay 30, 2025 Quick Ratio1.40 Sales Y/Y TTM-20.17% Profit Margin-4.71% RSI (14)41.40 Recom2.60
Dividend Gr. 3/5Y-1.25% 4.12% Current Ratio2.02 EPS Q/Q237.60% SMA20-2.98% Beta0.61 Target Price36.31
Payout- Debt/Eq1.46 Sales Q/Q-26.92% SMA50-2.34% Rel Volume0.47 Prev Close29.99
Employees38000 LT Debt/Eq1.36 EarningsMay 01 BMO SMA200-10.29% Avg Volume4.22M Price29.53
IPOMay 16, 1961 Option/ShortYes / Yes EPS/Sales Surpr.13.75% 1.45% Trades Volume916,432 Change-1.52%
Date Action Analyst Rating Change Price Target Change
Feb-26-25Resumed Goldman Buy $42
Feb-24-25Upgrade Argus Hold → Buy
Feb-20-25Resumed Barclays Overweight $39
Jul-15-24Downgrade Morgan Stanley Equal-Weight → Underweight $39 → $30
May-30-24Initiated Goldman Neutral $36
May-10-24Downgrade TD Cowen Buy → Hold $40
May-30-23Resumed Morgan Stanley Equal-Weight $45
Mar-29-23Initiated UBS Neutral $43
Jan-06-23Downgrade Morgan Stanley Overweight → Equal-Weight $55
Jan-05-23Downgrade Raymond James Outperform → Mkt Perform
Jun-20-25 07:47AM
Jun-18-25 07:34AM
Jun-04-25 07:47AM
01:45AM
May-27-25 04:15PM
10:48AM Loading…
May-21-25 10:48AM
May-20-25 02:00AM
May-19-25 11:33PM
May-06-25 04:15PM
May-02-25 03:04AM
12:53AM
May-01-25 01:27PM
12:36PM
11:46AM
09:30AM
07:15AM Loading…
07:15AM
Apr-30-25 10:54AM
Apr-29-25 04:15PM
Apr-28-25 01:19PM
Apr-21-25 04:57AM
Apr-15-25 09:50PM
04:15PM
Apr-14-25 09:48AM
Apr-10-25 01:16PM
09:16AM
Apr-03-25 06:57PM
Apr-02-25 08:50AM
Apr-01-25 10:01AM
Mar-26-25 09:00AM
Mar-24-25 05:05AM
02:48PM Loading…
Mar-23-25 02:48PM
02:32PM
Mar-17-25 07:37AM
Mar-11-25 05:03AM
Mar-04-25 09:00AM
Feb-25-25 04:15PM
07:54AM
04:02AM
Feb-24-25 06:48PM
Feb-21-25 09:35AM
02:06AM
Feb-20-25 11:55PM
04:57PM
12:41PM
10:49AM
10:30AM
09:06AM
08:05AM
07:15AM
Feb-19-25 08:07AM
Feb-18-25 04:15PM
Feb-17-25 04:15PM
Feb-13-25 04:15PM
Feb-12-25 08:05AM
Feb-11-25 04:30PM
Feb-10-25 09:16AM
Feb-04-25 07:19AM
Feb-03-25 07:56PM
08:07AM
07:30AM
07:00AM
Jan-24-25 07:00AM
Jan-22-25 04:15PM
07:00AM
Dec-23-24 12:48PM
Dec-20-24 07:44PM
Dec-18-24 04:15PM
Dec-11-24 08:00AM
Dec-10-24 08:32AM
Dec-04-24 09:36AM
Nov-20-24 11:52AM
Nov-19-24 04:15PM
Nov-13-24 04:15PM
12:19AM
Nov-12-24 04:15PM
Nov-11-24 06:45PM
Nov-09-24 02:37AM
02:04AM
Nov-08-24 11:42AM
09:30AM
08:45AM
07:40AM
07:15AM
Nov-05-24 09:15AM
Oct-29-24 05:17AM
Oct-23-24 04:15PM
Oct-22-24 01:52PM
11:47AM
Oct-18-24 02:00PM
09:40AM
Oct-16-24 04:15PM
Oct-15-24 01:05PM
Oct-11-24 05:52PM
Oct-10-24 06:07PM
10:37AM
09:49AM
Oct-09-24 02:24PM
Oct-04-24 05:07PM
04:55PM
01:34PM
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stevens BrianOfficerSep 16 '24Proposed Sale40.0197639,046Sep 16 04:46 PM
Stevens BrianOfficerSep 13 '24Proposed Sale39.8116,063639,465Sep 13 05:46 PM